Corbus Pharmaceuticals Holdings OverviewCorbus Pharmaceuticals Holdings Other Income Expense Net
Other Income/Expense Net for CRBP.
Quarterly Other Income/Expense
$1.33M
↓ 52.27% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$2.75M
↓ 59.99% YoY
Trailing 12 months ending Mar 31, 2026